Deuterium Capital Management, LLC - SENSEI BIOTHERAPEUTICS INC ownership

Back to all holdings Add to watchlist

SENSEI BIOTHERAPEUTICS INC's ticker is SNSE and the CUSIP is 81728A108. A total of 27 filers reported holding SENSEI BIOTHERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
Deuterium Capital Management, LLC ownership history of SENSEI BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$8,800
-64.9%
11,000
-50.0%
0.02%
+23.5%
Q2 2023$25,080
+52.0%
22,000
+100.0%
0.02%
-34.6%
Q1 2023$16,500
-6.9%
11,000
-7.6%
0.03%
-44.7%
Q4 2022$17,731–11,900–0.05%–
 Download
Other shareholders
SENSEI BIOTHERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Newtyn Management, LLC 1,540,920$2,311,3800.45%
Deuterium Capital Management, LLC 11,000$16,5000.03%
Duquesne Family Office 100,000$1500.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 112,900$169,3500.00%
LEO BROKERAGE, LLC 14,845$22,2680.00%
Ergoteles LLC 15,521$23,2820.00%
UBS Group AG 3,440$5,1600.00%
TWO SIGMA INVESTMENTS, LP 15,276$22,9140.00%
DIMENSIONAL FUND ADVISORS LP 11,570$17,3550.00%
BANK OF AMERICA CORP /DE/ 89,986$134,9790.00%
View complete list of SENSEI BIOTHERAPEUTICS INC shareholders